Board of Directors of the RPG Life Sciences at its meeting held on April 30, 2021 approved re-appointment of Mr. Yugal Sikri as the Managing Director of the Company for a period from October 1, 2021 to April 30, 2024.
Mr. Sikri is a Senior Pharma Industry Professional with rich and diverse experience in the pharmaceutical industry. Mr. Sikri is responsible for the overall conduct and management of the business and affairs of the Company. This includes broad development of domestic and international business; providing strategic direction to the three business units of the Company; review of product portfolio in light of patent laws and continual introduction of new products; enhancement of manufacturing efficiencies and rationalization of costs.
Mr. Sikri has successfully handled and overlooked domestic and international business for reputed companies like GlaxoSmithKline, Warner Lambert/ Pfizer, Novartis, Ranbaxy and RPGLS for many years. He is also an Independent Director on the Board of AIC-NMIMS Incubation Centre.